ArticleNeurosurgical review2026
The symptom spectrum: preoperative symptom-related indicators of surgical outcomes for adult type 1 chiari malformation.
Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chiari I malformation (C1M) may necessitate surgical decompression in adulthood due to the emergence of debilitating neurological symptoms. The outcomes of surgical management for C1M in the adult population are variable and predictive value of individual symptoms has been less extensively studied. A retrospective cohort study was conducted on adult patients (≥ 18 years) who underwent posterior fossa decompression surgery (PFDS) for C1M at our institution between 2004 and 2024. Univariate and multivariate analyses were performed to evaluate the predictive value of preoperative C1M-related symptoms on postoperative clinician-documented outcomes and complete symptom resolution at 30-, 90-day, and long-term follow-up. A total of 209 adult patients underwent PFDS for C1M, with a median age of 36 years and a male-to-female ratio of 1:4.9. Headache was the most common presenting symptom (91.4%), with tussive headaches present in 62.3% of cases with headache. Multivariate regression analysis identified preoperative sleep apnea (OR = 6.55, 95% CI: 1.16-37.05), imbalance (OR = 2.33, 95% CI: 1.12-4.84), and tinnitus (OR = 2.81, 95% CI: 1.14-6.89) as predictors of symptom improvement at 30-days follow-up, while dysphagia (OR = 5.80, 95% CI: 1.39-24.12) was predictive at 90-days. Patients with preoperative hearing loss were more likely to experience symptom recurrence during long-term follow-up (OR = 4.55, 95% CI: 1.04-19.77). Hand numbness/weakness and visual symptoms were the only two preoperative symptoms predictive of a lower odds of complete symptom resolution at the final follow-up (OR = 0.50 and OR = 0.42, respectively). Several clinical factors were associated with postoperative symptom outcomes after PFDS for C1M. These associations should be considered hypothesis-generating and require prospective validation before clinical application.
Indexed as
Identifiers
42728458What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.